Cedelizumab

Tax included
Cedelizumab (RWJ 49004) is a IgG4 monoclonal antibody targeting CD4. Cedelizumab has immunosuppressant properties.
MedChemExpress 
HY-P99495

Data sheet

Size
Multiple sizes
Reactivity
Others
CAS
156586-90-2